Abstract
Kawasaki hastalığı, sıklıkla 5 yaş altındaki çocukları etkileyen, koroner arter anomalisi gelişme riski taşıyan küçük-orta damar vaskülitidir. En az 5 gündür devam eden ateşten birkaç gün sonra diğer bulgular (eksudasız konjonktival hiperemi, eritemli orofarenks, çilek dili, çatlamış dudaklar, polimorfik, yaygın, eritematöz döküntü, eritemli el ayası ve ayak tabanı, tek taraflı, en az 1.5 cm çapında bir veya daha fazla servikal lenfadenopati) ortaya çıkar. Tedavide intravenöz immünglobulin ve yüksek doz asetil salisilik asit kullanılır. Bu olgu sunumunda Kawasaki hastalığının ilk 10 günü içinde sağlık güvencesinin olmaması nedeniyle intravenöz immünglobulin verilemeyen, bu nedenle yüksek doz asetil salisilik asit ve pulse metil prednizolon tercih edilen, ancak geç dönemde intravenöz immünglobulin tedavisi ile hastalığı kontrol altına alınabilen 12 yaşındaki bir kız hastanın klinik izlemi sunuldu.
References
- Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diag- nosis, management, and long-term implications. Cardiol Rev. 2007;15:163–169.
- Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am. 1999;46:313–329.
- Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250–252.
- Sève P, Stankovic K, Smail A, Durand DV, Marchand G, Brous- solle C. Adult Kawasaki disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785–792
- Newburger JW, Taubert KA, Shulman ST, Rowley AH, Gewitz MH, Takahashi M, McCrindle BW. Summary and abstracts of the seventh International Kawasaki Disease Symposium: December 4-7, 2001. Pediatr Res. 2003;53:153–157.
Abstract
Kawasaki disease occurs predominantly in children younger than 5 years of age. The disease is a febrile, multisystem illness of importance because of the risk of development of coronary artery abnormalities. Kawasaki disease is a generalized systemic vasculitis involving small to medium blood vessels throughout the body. Within several days of the onset of fever (persisting for at least 5 days), other characteristic features of the illness usually appear, including conjunctival infection without exudates; erythematous mouth and pharynx, strawberry tongue, and red, cracked lips; a polymorphous, generalized, erythematous rash; erythematous palms and soles; a unilateral cervical lymph node enlarged to at least 1.5 cm in diameter. Treatment with intravenous immunoglobulin and high-dose acetyl salicylic acid remains the primary management strategy. We report a case of acute Kawasaki disease in a 12-year-old girl who could not be given intravenous immunoglobulin in the first 10 days of the illness because of social security problems. Although she was given high-dose aspirin and steroids in the acute phase, she was successfully treated with intravenous immunoglobulin in the subacute phase
References
- Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diag- nosis, management, and long-term implications. Cardiol Rev. 2007;15:163–169.
- Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am. 1999;46:313–329.
- Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250–252.
- Sève P, Stankovic K, Smail A, Durand DV, Marchand G, Brous- solle C. Adult Kawasaki disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785–792
- Newburger JW, Taubert KA, Shulman ST, Rowley AH, Gewitz MH, Takahashi M, McCrindle BW. Summary and abstracts of the seventh International Kawasaki Disease Symposium: December 4-7, 2001. Pediatr Res. 2003;53:153–157.
Details
| Other ID | JA25HE47VK |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | August 1, 2009 |
| Submission Date | August 1, 2009 |
| Published in Issue | Year 2009 Volume: 3 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.